These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2879210)

  • 1. Changes in plasma growth hormone in diabetic and nondiabetic subjects during the glucose clamp.
    Sharp PS; Mohan V; Maneschi F; Vitelli F; Cloke HR; Burrin JM; Kohner EM
    Metabolism; 1987 Jan; 36(1):71-5. PubMed ID: 2879210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
    Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
    J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effect of levodopa and somatostatin on the plasma levels of growth hormone, insulin, glucagon and prolactin in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):167-74. PubMed ID: 1269163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
    Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests.
    Brehm A; Thomaseth K; Bernroider E; Nowotny P; Waldhäusl W; Pacini G; Roden M
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2272-8. PubMed ID: 16595595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.
    Ryan AS; Egan JM; Habener JF; Elahi D
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2399-404. PubMed ID: 9661618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further defects in counterregulatory responses induced by recurrent hypoglycemia in IDDM.
    Davis MR; Mellman M; Shamoon H
    Diabetes; 1992 Oct; 41(10):1335-40. PubMed ID: 1397708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects.
    Hansen IL; Cryer PE; Rizza RA
    Diabetes; 1985 Aug; 34(8):751-5. PubMed ID: 3894118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin does not alter insulin-mediated glucose disposal.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.
    Nielsen MF; Basu R; Wise S; Caumo A; Cobelli C; Rizza RA
    Diabetes; 1998 Nov; 47(11):1735-47. PubMed ID: 9792543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dawn phenomenon: comparison between normal and insulin-dependent diabetic adolescents.
    Arslanian S; Ohki Y; Becker DJ; Drash AL
    Pediatr Res; 1992 Mar; 31(3):203-6. PubMed ID: 1313957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth hormone response to arginine administration in diabetics--with special reference to the multiple regression analysis in association with diabetic retinopathy].
    Kitada M; Yasuda K; Takeda N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jun; 65(6):558-71. PubMed ID: 2792459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol, glucagon and growth hormone responses to oral glucose in non-insulin-dependent diabetes in the young.
    Jialal I; Joubert SM
    S Afr Med J; 1982 Oct; 62(16):549-52. PubMed ID: 6750813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
    Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
    J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.